{"transactions":[{"id":4618136,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-09-15T20:30:38.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the options vested on May 1, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to the options vests every month thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":133840,"derivative":{"exercise_price":1.35,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001993684-26-000008","document":"form4-09152026_040933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1993684/000199368426000008/form4-09152026_040933.xml","form_type":"4"}},{"id":4618135,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:30:38.000Z","date":"2026-09-11","kind":"gift","planned":true,"acquired":false,"shares":8800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":56250,"source":{"system":"sec-edgar","filing":"0001993684-26-000008","document":"form4-09152026_040933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1993684/000199368426000008/form4-09152026_040933.xml","form_type":"4"}},{"id":4618134,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:30:38.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":13200,"price":25.32,"value":334224.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."}],"balance_after":65050,"source":{"system":"sec-edgar","filing":"0001993684-26-000008","document":"form4-09152026_040933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1993684/000199368426000008/form4-09152026_040933.xml","form_type":"4"}},{"id":4618133,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:30:38.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":1.35,"value":24300.0,"ownership":{"direct":true},"balance_after":78250,"source":{"system":"sec-edgar","filing":"0001993684-26-000008","document":"form4-09152026_040933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993684/000199368426000008/form4-09152026_040933.xml","form_type":"4"}},{"id":702955,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-27T20:10:12.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":76500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":76500,"derivative":{"exercise_price":22.01,"expiration_date":"2036-07-22","underlying":"Common Stock","underlying_shares":76500},"source":{"system":"sec-edgar","filing":"0001993684-26-000006","document":"form4-07272026_040707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368426000006/form4-07272026_040707.xml","form_type":"4"}},{"id":702954,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-27T20:10:12.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":38250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock (\"Common Stock\") underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":60250,"source":{"system":"sec-edgar","filing":"0001993684-26-000006","document":"form4-07272026_040707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368426000006/form4-07272026_040707.xml","form_type":"4"}},{"id":816262,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-04-03T23:48:14.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":9438,"price":21.64,"value":204238.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."}],"balance_after":22000,"source":{"system":"sec-edgar","filing":"0001993684-26-000004","document":"form4-04032026_110409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368426000004/form4-04032026_110409.xml","form_type":"4"}},{"id":822787,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-04-01T21:39:15.000Z","date":"2026-03-30","kind":"gift","planned":false,"acquired":false,"shares":6291,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31438,"source":{"system":"sec-edgar","filing":"0001993684-26-000002","document":"form4-04012026_090411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368426000002/form4-04012026_090411.xml","form_type":"4"}},{"id":960881,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:43:46.000Z","date":"2025-12-19","kind":"gift","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Custodian for Child 3"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account for the child of the Reporting Person established pursuant to the Uniform Transfer to Minors Act, for which the Reporting Person serves as a custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares are subject to a lockup agreement entered into by the Reporting Person on December 15, 2025 (the \"Lock-up Agreement\").  The transferee has agreed to be bound by the terms of the Lock-up Agreement."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001993684-25-000004","document":"form4-12222025_121242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368425000004/form4-12222025_121242.xml","form_type":"4"}},{"id":960880,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:43:46.000Z","date":"2025-12-19","kind":"gift","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account for the child of the Reporting Person established pursuant to the Uniform Transfer to Minors Act, for which the Reporting Person serves as a custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose."}],"balance_after":37729,"source":{"system":"sec-edgar","filing":"0001993684-25-000004","document":"form4-12222025_121242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368425000004/form4-12222025_121242.xml","form_type":"4"}},{"id":960879,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:43:46.000Z","date":"2025-12-19","kind":"gift","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Custodian for Child 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account for the child of the Reporting Person established pursuant to the Uniform Transfer to Minors Act, for which the Reporting Person serves as a custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares are subject to a lockup agreement entered into by the Reporting Person on December 15, 2025 (the \"Lock-up Agreement\").  The transferee has agreed to be bound by the terms of the Lock-up Agreement."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001993684-25-000004","document":"form4-12222025_121242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368425000004/form4-12222025_121242.xml","form_type":"4"}},{"id":960878,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:43:46.000Z","date":"2025-12-19","kind":"gift","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account for the child of the Reporting Person established pursuant to the Uniform Transfer to Minors Act, for which the Reporting Person serves as a custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose."}],"balance_after":38729,"source":{"system":"sec-edgar","filing":"0001993684-25-000004","document":"form4-12222025_121242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368425000004/form4-12222025_121242.xml","form_type":"4"}},{"id":960877,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:43:46.000Z","date":"2025-12-19","kind":"gift","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Custodian for Child 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account for the child of the Reporting Person established pursuant to the Uniform Transfer to Minors Act, for which the Reporting Person serves as a custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares are subject to a lockup agreement entered into by the Reporting Person on December 15, 2025 (the \"Lock-up Agreement\").  The transferee has agreed to be bound by the terms of the Lock-up Agreement."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001993684-25-000004","document":"form4-12222025_121242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368425000004/form4-12222025_121242.xml","form_type":"4"}},{"id":960876,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:43:46.000Z","date":"2025-12-19","kind":"gift","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account for the child of the Reporting Person established pursuant to the Uniform Transfer to Minors Act, for which the Reporting Person serves as a custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose."}],"balance_after":39729,"source":{"system":"sec-edgar","filing":"0001993684-25-000004","document":"form4-12222025_121242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368425000004/form4-12222025_121242.xml","form_type":"4"}},{"id":1042755,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock option (right to buy)","published_at":"2025-09-12T01:04:17.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":151840,"derivative":{"exercise_price":1.35,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001415889-25-024319","document":"form4-09122025_010912.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925024319/form4-09122025_010912.xml","form_type":"4"}},{"id":1042754,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-09-12T01:04:17.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":true,"shares":22000,"price":1.35,"value":29700.0,"ownership":{"direct":true},"balance_after":40729,"source":{"system":"sec-edgar","filing":"0001415889-25-024319","document":"form4-09122025_010912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925024319/form4-09122025_010912.xml","form_type":"4"}},{"id":1078352,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-31T22:52:43.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":196000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":196000,"derivative":{"exercise_price":10.6,"expiration_date":"2035-07-28","underlying":"Common Stock","underlying_shares":196000},"source":{"system":"sec-edgar","filing":"0001415889-25-020784","document":"form4-07312025_100740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925020784/form4-07312025_100740.xml","form_type":"4"}},{"id":1188794,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock option (right to buy)","published_at":"2025-03-28T21:54:02.000Z","date":"2025-03-27","kind":"exercise","planned":false,"acquired":false,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":173840,"derivative":{"exercise_price":1.35,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":5200},"source":{"system":"sec-edgar","filing":"0001415889-25-009201","document":"form4-03282025_090359.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925009201/form4-03282025_090359.xml","form_type":"4"}},{"id":1188793,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-28T21:54:02.000Z","date":"2025-03-27","kind":"exercise","planned":false,"acquired":true,"shares":5200,"price":1.35,"value":7020.0,"ownership":{"direct":true},"balance_after":18729,"source":{"system":"sec-edgar","filing":"0001415889-25-009201","document":"form4-03282025_090359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925009201/form4-03282025_090359.xml","form_type":"4"}},{"id":1429277,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-08-20T01:05:08.000Z","date":"2024-08-15","kind":"exercise","planned":false,"acquired":false,"shares":19524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":179040,"derivative":{"exercise_price":1.35,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":19524},"source":{"system":"sec-edgar","filing":"0001415889-24-021656","document":"form4-08202024_010805.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588924021656/form4-08202024_010805.xml","form_type":"4"}},{"id":1429276,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-08-20T01:05:08.000Z","date":"2024-08-19","kind":"gift","planned":false,"acquired":false,"shares":2471,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13529,"source":{"system":"sec-edgar","filing":"0001415889-24-021656","document":"form4-08202024_010805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588924021656/form4-08202024_010805.xml","form_type":"4"}},{"id":1429275,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-08-20T01:05:08.000Z","date":"2024-08-15","kind":"sale","planned":false,"acquired":false,"shares":3524,"price":13.925,"value":49071.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to sell to cover transactions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction report was $13.925, and the range of prices were between $13.800 and $14.020. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001415889-24-021656","document":"form4-08202024_010805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588924021656/form4-08202024_010805.xml","form_type":"4"}},{"id":1429274,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-08-20T01:05:08.000Z","date":"2024-08-15","kind":"exercise","planned":false,"acquired":true,"shares":19524,"price":1.35,"value":26357.4,"ownership":{"direct":true},"balance_after":19524,"source":{"system":"sec-edgar","filing":"0001415889-24-021656","document":"form4-08202024_010805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588924021656/form4-08202024_010805.xml","form_type":"4"}},{"id":1434785,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-08-13T21:36:26.000Z","date":"2024-08-09","kind":"grant","planned":false,"acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on August 9, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":190000,"derivative":{"exercise_price":12.92,"expiration_date":"2034-08-08","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001415889-24-021226","document":"form4-08132024_090822.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588924021226/form4-08132024_090822.xml","form_type":"4"}},{"id":1721523,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-12-06T02:08:56.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 1, 2023, Dr. Higgins was granted an option to purchase 200,000 shares of common stock.  The option vests (i) with respect to 100,000 shares, 25% of such shares subject to the option, vest on November 17, 2024, and the remaining shares will vest monthly thereafter over three years, and (ii) with respect to the remaining 100,000 shares, which vesting shall commence as of the date a certain condition set forth in Dr. Higgins' Amended and Restated Offer Letter dated November 30, 2023, is satisfied, 25% of the shares subject to the option will vest 1 year from the completion of that certain condition, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":200000,"derivative":{"exercise_price":7.8,"expiration_date":"2033-11-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-23-057567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919123057567/doc4.xml","form_type":"4"}}]}